Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001200330 | SCV001371256 | pathogenic | not provided | 2020-04-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001200330 | SCV002247271 | pathogenic | not provided | 2024-10-16 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 34 of the C1QC protein (p.Gly34Arg). This variant is present in population databases (rs200206736, gnomAD 0.03%). This missense change has been observed in individual(s) with classical pathway complement deficiencies (PMID: 7900940, 8630118, 28082982, 30008451, 31357913). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as p.Gly6Arg. ClinVar contains an entry for this variant (Variation ID: 17071). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. |
Mendelics | RCV000018600 | SCV002518619 | pathogenic | C1Q deficiency | 2022-05-04 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000018600 | SCV000038883 | pathogenic | C1Q deficiency | 1996-04-01 | no assertion criteria provided | literature only |